Literature DB >> 11100977

(-)1-(Benzofuran-2-yl)-2-propylaminopentane shows survival effect on cortical neurons under serum-free condition through sigma receptors.

W Hamabe1, R Fujita, T Yasusa, F Yoneda, A Yoshida, H Ueda.   

Abstract

1. The rapid cell death of cortical neurons in serum-free culture was rescued by the condition medium from the high-density culture, but not by brain-derived neurotrophic factor or basic fibroblast growth factor. 2. Similar rescue was observed by the addition of (-)BPAP, an impulse enhancer, and (+)-pentazocine, a sigma receptor agonist. These actions were blocked by BD1063, a sigma receptor antagonist. 3. (-)BPAP showed a weak displacement activity in the [3H]pentazocine binding to synaptic membranes from rat cerebral cortex. 4. These findings suggest that (-)BPAP and (+)-pentazocine have unique survival activity on cortical neurons through sigma receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100977     DOI: 10.1023/a:1007050808754

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  19 in total

1.  Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents.

Authors:  M J Pontecorvo; E W Karbon; S Goode; D B Clissold; S A Borosky; R J Patch; J W Ferkany
Journal:  Brain Res Bull       Date:  1991-03       Impact factor: 4.077

2.  (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.

Authors:  J Knoll; F Yoneda; B Knoll; H Ohde; I Miklya
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats.

Authors:  H Takahashi; J R Kirsch; K Hashimoto; E D London; R C Koehler; R J Traystman
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

4.  sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures.

Authors:  S Shimazu; H Katsuki; C Takenaka; M Tomita; T Kume; S Kaneko; A Akaike
Journal:  Eur J Pharmacol       Date:  2000-01-28       Impact factor: 4.432

5.  Serum-free induced neuronal apoptosis-like cell death is independent of caspase activity.

Authors:  W Hamabe; N Fukushima; A Yoshida; H Ueda
Journal:  Brain Res Mol Brain Res       Date:  2000-05-31

Review 6.  (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain.

Authors:  J Knoll
Journal:  Pharmacol Toxicol       Date:  1998-02

7.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

8.  Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Authors:  P G Lysko; R C Gagnon; T L Yue; J L Gu; G Feuerstein
Journal:  Stroke       Date:  1992-03       Impact factor: 7.914

9.  Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.

Authors:  R R Matsumoto; W D Bowen; M A Tom; V N Vo; D D Truong; B R De Costa
Journal:  Eur J Pharmacol       Date:  1995-07-14       Impact factor: 4.432

Review 10.  Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models.

Authors:  K Kitani; S Kanai; G O Ivy; M C Carrillo
Journal:  Ann N Y Acad Sci       Date:  1998-11-20       Impact factor: 5.691

View more
  1 in total

Review 1.  Enhancer regulation/endogenous and synthetic enhancer compounds: a neurochemical concept of the innate and acquired drives.

Authors:  Joseph Knoll
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.